0001437749-19-006428.txt : 20190402
0001437749-19-006428.hdr.sgml : 20190402
20190402192724
ACCESSION NUMBER: 0001437749-19-006428
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190401
FILED AS OF DATE: 20190402
DATE AS OF CHANGE: 20190402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ESBER HENRY JEMIL
CENTRAL INDEX KEY: 0001391501
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-52991
FILM NUMBER: 19727069
MAIL ADDRESS:
STREET 1: 38 ANGELL BROOK DRIVE
CITY: WEST BOYLSTON
STATE: MA
ZIP: 01853
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INNOVUS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001411879
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 900814124
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8845 REHCO ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-964-5123
MAIL ADDRESS:
STREET 1: 8845 REHCO ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: North Horizon, Inc.
DATE OF NAME CHANGE: 20070910
4
1
rdgdoc.xml
FORM 4
X0306
4
2019-04-01
0001411879
INNOVUS PHARMACEUTICALS, INC.
INNV
0001391501
ESBER HENRY JEMIL
8845 REHCO ROAD
SAN DIEGO
CA
92121
1
Restricted Stock Units
2019-04-01
4
A
0
1643
5.48
A
2019-04-01
2029-04-01
Common Stock
1643
28734
D
Each restricted stock unit represents the contingent right to receive, at settlement, one share of common stock.
The Reporting Person was granted a Restricted Stock Unit on April 1, 2019 of 1,643 shares, which were fully vested on the date of the grant. The RSU is for the Reporting Person's quarterly compensation as a member of the Board of Directors for the first quarter of 2019 and was valued on March 29, 2019 in accordance with the approved compensation plan for the non-employee members of the Board of Directors.
These restricted stock units were granted pursuant to the Issuer's Amended and Restated 2016 Equity Incentive Plan.
/s/ HENRY ESBER
2019-04-02